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Abstract 
 The occurrence of trace organic contaminants in wastewaters, their behaviour 
during wastewater treatment and drinking water production are the key issues in relation to 
the reuse of water resources. Elimination of different classes of emerging contaminants, 
such as surfactant degradates, pharmaceuticals and polar pesticides in wastewater 
treatment plants (WWTP) was found to be rather low and consequently sewage effluents 
are one of the main sources of these compounds and their recalcitrant metabolites.  
This paper reviews the state-of-the-art in the analysis of several groups of emerging 
contaminants (acidic pharmaceuticals, antibacterial agents, acidic pesticides and surfactant 
metabolites) in wastewaters. Their elimination in WWTP applying conventional activated 
sludge treatment and advanced treatment processes, such as membrane bioreactors (MBR) 
and advanced oxidation (AOP), as well as the elimination during drinking water 
production are discussed.  
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1. Introduction 
 
Until the beginning of the 1990’ non-polar hazardous compounds, i. e. persistent 
organic pollutants (POP) and heavy metals, were in the focus of interest and awareness as 
priority pollutants, and consequently were part of intensive monitoring programs. Today, 
these compounds are less relevant for the industrialized countries since a drastic reduction 
of emission has been achieved due to the adoption of appropriate measures and elimination 
of the dominant pollution sources.  
However, the emission of so-called “emerging” or “new” unregulated contaminants 
has emerged as an environmental problem and there is a widespread consensus that this 
kind of contamination may require legislative intervention. This group is mainly composed 
of products used in large quantities in everyday life, such as human and veterinary 
pharmaceuticals, personal care products, surfactants and surfactants’ residues, plasticizers 
and different industrial additives. The characteristic of these contaminants is that they do 
not need to be persistent in the environment to cause negative effect since their high 
transformation/removal rates can be compensated by their continuous introduction into 
environment. One of the main sources of emerging contaminants are untreated urban 
wastewaters and wastewater treatment plant (WWTP) effluents. (Fig. 1). Most current 
WWTP are not designed to treat this type of substances and the high portion of emerging 
compounds and their metabolites can escape elimination in the WWTP and enter the 
aquatic environment via sewage effluents.  
The partial or complete closing of water cycles is an essential part of sustainable 
water resources management and the increasing scarcity of pristine waters for drinking 
water supply and increasing consume of water by industry and agriculture should be 
countered by the efficient and rational utilisation of resources. One of the options is 
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increasing reuse of effluents for various purposes, especially in industrial and agro/food 
production activities. However, due to high cost of end-of-pipe approach (drinking water 
treatment) the future of indirect potable reuse requires an efficient treatment of 
wastewaters prior to their discharge. Thus, the occurrence of trace organic contaminants in 
wastewaters, their behaviour during wastewater treatment and drinking water production 
are the key issues that require further study.  
Many believe that of all emerging contaminants, antibiotics are the biggest concern, 
since their emission in the environment can result in an increased occurrence of resistant 
bacteria in the environment [1]. However, other emerging compounds, especially polar 
one, such as acidic pharmaceuticals, acidic pesticides and acidic metabolites of non-ionic 
surfactants also deserve particular attention. Due to their physico-chemical properties (high 
water solubility and often poor degradability) they are able to penetrate through all natural 
filtration steps and man-made treatments, thus presenting a potential risk for drinking 
water supply [2,3].  
Different classes of emerging contaminants, mainly surfactant degradates, 
pharmaceuticals and personal care products (PPCP) and polar pesticides were found to 
have rather low elimination rates and have been detected in WWTP effluents and in the 
receiving surface waters. However, for most of emerging contaminants, occurrence, risk 
assessment and ecotoxicological data are not available and it is difficult to predict their fate 
in the aquatic environment. Partially, the reason for this is a lack of analytical methods for 
their determination at trace concentrations. Analysis of emerging contaminants is a real 
analytical challenge, not only because of the diversity of chemical properties of these 
compounds, but also because of generally low concentrations (usually part per billion or 
part per trillion levels) and the complexity of matrices.  
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This paper reviews the state-of-the-art in the analysis of several groups of emerging 
contaminants (acidic pharmaceuticals, antibacterial agents, acidic pesticides and surfactant 
metabolites) in wastewaters. Various aspects of current LC-MS-(MS) and GC-MS 
methodology, including sample preparation, are discussed.  
It also gives a survey of their elimination in WWTP by activated sludge treatment 
(AST) and applying advanced treatment processes, such as membrane bioreactors (MBR) 
and advanced oxidation (AOP). Additionally, the elimination in treatment processes at 
drinking water treatment plants is discussed.  
 
 
2. Analysis of emerging contaminants in wastewaters 
 
One of the major limitations in the analysis of emerging contaminants remains to be 
the lack of analytical methods for quantification of low concentrations. The prerequisite for 
proper risk assessment and monitoring of waste, surface and drinking water quality is the 
availability of a multiresidual analytical method that permits measurement at the low (or 
even below) ng/L level. However, the fact that these compounds are not on the regulatory 
lists as environmental pollutants resulted in comparatively little attention received. 
Consequently, analytical methodology for different groups of emerging contaminants is 
evolving and the number of methods described in the literature for the determination of 
emerging contaminants has grown considerably. Still, the analysis of this group of 
contaminants requires further improvements in terms of sensitivity and selectivity, 
especially for very complex matrices, such as wastewater.  
 5
2.1. Acidic pharmaceuticals 
 
Different analytical methods, mainly based on LC-MS and GC-MS, repectively in 
combination with either polymer or C18-based solid phase extraction (SPE), are being 
developed for the analysis of pharmaceutical compounds. However, most methods are 
tailored for neutral compounds (e.g. antibiotics) and less complex matrices (surface and 
groundwater), while only a limited number of paper describes procedures applicable to the 
analysis of polar drugs in wastewater samples. A survey of analytical methods for the 
quantification of regularly used polar pharmaceuticals in wastewater matrices is given in 
Table 1. 
A typical analytical method includes the use of octadecylsilica, polymeric, or 
hydrophilic-lipophilic balanced (HBL) supports for off-line SPE of water samples, with 
either disks or, most frequently, cartridges at low pH (typically pH=2).  
Separation technique used includes both GC and LC, while for detection, MS has 
been the technique most widely employed. Due to low volatility of polar pharmaceuticals 
GC-MS analysis requires additional derivatization step, which makes the sample 
preparation laborious and time consuming, and also increases the possibility of 
contamination and errors. Moreover, some compounds are thermolabile and decompose 
during GC analysis (e.g. carbamazepine forms iminostilben as degradation product) [4].  
Consequently, LC-MS and LC-MS-MS are increasingly used. Reviewing principal 
analytical methods employed in the analysis of pharmaceuticals in aqueous environmental 
samples Ternes [4] indicated LC-MS-MS as the technique of choice to assay polar 
pharmaceuticals and their metabolites, however pointed out the difficulty in the enrichment 
step, as well as the low resolution and the suppression of signals in the electrospray (ESI) 
interface due to matrix impurities. Farré et al. [5] have compared LC-(ESI)-MS and GC-
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MS (after a derivatization with BF3-MeOH) for the monitoring of some acidic and very 
polar analgesics (salicylic acid, ketoprofen, naproxen, diclofenac, ibuprofen and 
gemfibrozil) in surface waters and wastewater samples. Results showed a good correlation 
between methods expect for the gemfibrozil which derivatization was not completely 
achieved in some samples. 
In general, the limits of detection (LODs) achieved with the LC-MS-(MS) methods 
were slightly higher than those obtained with the GC-MS methods (see Table 1), however, 
LC-MS methodology showed advantages in terms of versatility and less complicated 
sample preparation (no derivatization needed).  
Table 2 summarizes the quantitation and qualifier ions used by the various authors 
for the determination of polar drugs in wastewaters using the selected ion monitoring 
(SIM) or the multiple reaction monitoring (MRM) mode. The use of triple-quadropole 
mass spectrometers in LC analysis has substantially increased the selectivity and 
sensitivity of the determination, resulting in LODs better than those achieved by use of 
single-quadropole LC-MS. Acidic drugs were usually detected using an ESI interface 
under negative ionization conditions and deprotonated molecules where chosen as 
precursor ions. Typical fragmentation pattern obtained with LC-MS-MS showed a loss of 
CO2 (or loss of the acidic moiety), with a limited number of other products. For example, 
for diclofenac, ibuprofen and ketoprofen the product ions generated by expulsion of CO2 
were the only fragment ions formed.  
 
2.2. Acidic pesticides 
 
Chlorinated phenoxy acid herbicides account for the majority of pesticides used 
worldwide and their presence in environmental waters is well documented. However, their 
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behaviour during wastewater treatment was rarely studied. This group of herbicides is 
characterized by high polarity and thermal lability. For these reasons LC is generally more 
suitable for their analysis, as the sample pretreatment does not require a time-consuming 
derivatization step. However, the methods used to determine chlorinated phenoxy acid 
herbicides are still dominated by GC either with electron capture detector (ECD) or MS 
detection. The main disadvantage of GC analysis is that requires prior derivatization step, 
usually using highly toxic and carcinogenic diazomethane or, less frequently used, acid 
anhydrides, benzyl halides and alkylchloroformates. The injection-port derivatization with 
an ion-pair reagent has been successfully applied [6], as well as, in-situ derivatization prior 
to solid-phase microextraction (SPME) [7].  
Alternative methods based on LC-MS have been proposed, using an ESI interface, 
which is well suited to the determination of easily ionized chlorinated phenoxy acids. 
Using LC-MS-(MS), phenoxy acid herbicides are detected under negative ionization 
conditions typically yielding [M−H]− ion and one abundant fragment formed by the loss of 
acidic moiety [8,9].  
Recently, in-tube SPME followed by LC-MS was applied for the determination of 
six chlorinated phenoxy acid herbicides [10]. However, method was applied to river water 
achieving LODs ranging from 5 to 30 ng/l, while more complex wastewater matrix was not 
tested. 
 
2.3. Antiseptics 
 
Several methods have been proposed for the determination of triclosan (5-chloro-2-
[2,4-dichlorophenoxy] phenol), which is used as an antiseptic agent in a vast array of 
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personal care (e.g. toothpaste, acne cream, deodorant, shampoo, toilet soap) and consumer 
products (children’s toys, footwear, kitchen cutting boards).  
Methods based on diazomethane derivatization and capillary GC-ECD was applied 
for their quantification in the wastewater of a slaughterhouse [11], using silica clean up 
without derivatization and analysis by GC-MS [12] and SPE of acidified wastewater water 
samples and SFE for lyophilized sludge, respectively followed by derivatization and GC-
HRMS were recently developed [13]. 
Recently, a method based on LC-MS was also proposed, achieving a limit of 
detection of 0.35 μg/L in spiked urban wastewater [14].  
 
2.4. Alkylphenolic compounds 
 
The trace analysis of alkylphenol ethoxylates (APEOs) and their acidic metabolites 
by LC-MS or LC-MS-MS using atmospheric pressure ionization (API) has been recently 
reviewed by Petrovic et al. [15,16] and the performances of two ionization methods, APCI 
and ESI, in terms of selectivity and sensitivity toward oligomeric mixtures of APEOs has 
been discussed. Generally, ESI interface is more often used for the analysis of 
alkylphenolic compounds due to the higher sensitivity, especially for alkylphenols and 
carboxylated compounds. 
Alkylphenoxy carboxylates (APEC) were detected, in both, the NI and PI mode. In 
the NI mode, using ESI, APECs give two types of ions, one corresponding to the 
deprotonated molecule [M-H]– (m/z 277, 321, 263 and 307 corresponding to nonylphenol 
carboxylate (NPE1C), nonylphenol ethoxycarboxylate (NPE2C), octylphenol carboxylate 
(OPE1C), and octylphenol ethoxycarboxylate (OPE2C), respectively) and the other 
corresponding to deprotonated alkylphenols [17]. The relative abundance of these two ions 
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depends on the extraction voltage. In the presence of ammonium acetate and using an 
APCI under PI conditions NPE1C gave [M+NH4]+ ions at m/z 296, while NPE2C, gave 
[M+NH4]+ ion at m/z 340 [18]. 
LC-ESI-MS was also applied for the analysis of the dicarboxylated breakdown 
products (carboxylated alkylphenoxy carboxylates; CAPECs) in wastewaters [19,20]. 
However, the identification of these compounds using LC-MS, under conditions giving 
solely molecular ions, is difficult since CAnPEmCs have the same molecular mass as 
APECs having one ethoxy unit less and a shorter alkyl chain (An-1PEm-1C). Moreover, 
since some compounds partially co-elute, the unequivocal assignment of the individual 
fragments can be accomplished only using LC-MS-MS. Typical fragmentation pattern 
obtained with LC-ESI-MS-MS showed the formation of the carboxy-alkylphenoxy 
fragment, with an additionally lost CO2, or an acetic acid group, in the case of CA5PE1-2C 
leading to the fragments of m/z 149 and 133 [19]. 
MS-MS spectra of APECs [19,21,22] shows an intense signal at m/z 219 (for 
NPECs) and m/z 205 (for OPECs) that is produced after the loss of the carboxylated 
(ethoxy) moiety, while sequential fragmentation of the alkyl chain resulted in ions m/z 133 
and 147.  
To overcome the problem with the low volatility of acidic alkylphenolic 
compounds different off-line and on-line derivatization protocols, respectively have been 
developed. Off-line derivatization to corresponding triemethylsilyl ethers, methyl ethers, 
acetyl esters, pentafluorobenzoyl, or heptafluorobutyl esters, respectively was applied as a 
common approach in GC-MS analysis. On-line direct GC injection-port derivatization 
using ion-pair reagents (tetraalkylammonium salts), has been also reported [23].  The most 
significant ions in GC-(EI)-MS of methylated NPECs were fragments produced by rupture 
of the benzylic bond in the branched nonyl side-chain [23,24,25]. GC-CI-MS spectra of 
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the NPECs with isobutane as reagent gas showed characteristic hydride ion-abstracted 
fragment ions shifted by 1 Da from those in the corresponding EI mass spectra [22]. Using 
ammonia as reagent gas intense ammonia-molecular ion adducts of the methyl esters, with 
little, or no secondary fragmentation were reported for the detection of NPECs [26]. Ions 
selected were as follows: m/z 246, 310, 354 and 398 for NPE1C, NPE2C, NPE3C and 
NPE4C, respectively.  
 
 
3. Elimination by activated sludge treatment (AST) 
 
The present state-of-the-art of wastewater treatment involves treatment by the 
activated sludge treatment (AST) process proceeded with conventional physico-chemical 
pre-treatment steps. Table 3. summarizes data on the elimination of emerging contaminants 
in WWTP.  
 
 
3.1. Pharmaceuticals and personal care products 
 
Daughton and Ternes [1] reviewed the occurrence of over 50 individual PPCPs, or 
metabolites from more than 10 broad classes of therapeutic agents, or personal care 
products in environmental samples, mainly in WWTP effluents, surface, and ground waters 
and much less frequently in drinking waters. Acidic drugs are the major group of PPCPs 
detected in municipal WWTP and among them bezafibrate, naproxen, and ibuprofen were 
the most abundant (concentrations up to 4.6 μg/l were detected in German municipal 
WWTPs). Tixier et al. [27] determined that carbamezapine presented the highest daily load 
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from the WWTP into Lake Greifensee (Switzerland), followed by diclofenac, and 
naproxen. Their elimination during passage through a municipal sewage treatment in most 
cases was found to be quite low (see table 3), ranging from 35 to 90% and some 
compounds, like carbamazepine, exhibit extremely low removal (only 7%) [28]. 
Consequently, through sewage effluents they can enter receiving surface waters and thus 
become a potential risk in the production of drinking water. For example, the clofibric 
acid, a metabolite of three lipid regulating agents (clofibrate, etofibrate and fenofibrate) has 
been identified in river and ground water and even in drinking water at concentrations 
ranging up to 165 ng/l [29,30].  
 
3.2. Acidic Pesticides 
 
Chlorinated phenoxyacids are a kind of compounds widely used in agriculture. This 
group includes, for example, mecoprop (MCPP), MCPA, 2,4-D, 2,4-DP 2,4,5-T, 2,4-DB. 
Monitoring of these herbicides is important in surface water because of their potential 
toxicity towards animals and humans [31], however, these compounds are not only used 
for agricultural purposes, but also as herbicides on lawns, algicides in paints and coatings 
or as roof protection agents in flat roof sealings. So, residues of these substances are 
introduced into the aquatic system through different pathways. For example, in the 
catchment area of Lake Greifensee (Switzerland) 65% of the mecoprop originated from 
WWTPs and the remaining 35% from diffuse sources [32].  
Degradation of acidic pesticides under laboratory conditions is well studied, but 
there are only few publications dealing with their behaviour in real wastewater treatment 
processes. Generally, activated sludge treatment was found to be ineffective in removing 
chlorinated phenoxy acid herbicides from settled sewage. However, under laboratory 
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conditions mecoprop proved to be biodegradable (nearly 100%), however it required long 
adaptation time (lag-phase) of activated sludge [33]. In real wastewater treatment 
processes this presents a major difficulty since, like the majority of herbicides, mecoprop is 
applied only during a short growth period of plants, which means that during this period 
WWTPs, that contains a non-adapted activated sludge, receive shock-loads of herbicides 
and consequently these substances are not eliminated.  
A long acclimation period (about 4 months) was also observed in a bench-scale 
study using sequencing batch reactors before 2,4-D biodegradation was established [34].  
Afterwards, at steady-state operation, all reactors achieved practically complete removal 
(>99%) of 2,4-D. 
  
3.3. Alkylphenolic surfactants 
 
Although their environmental acceptability is strongly disputed APEOs are still 
among the most widely used non-ionic surfactants. Currently, under optimised conditions, 
more than 90-95% of surfactants are eliminated by conventional biological wastewater 
treatment (normally activated sludge treatment). Even if such high elimination rates are 
achieved, the principal problem is the formation of recalcitrant metabolites out of the 
parent surfactants. The widespread occurrence of APEO-derived compounds in treated 
wastewaters and the following disposal of effluents into aquatic system raise concerns 
about their impact on the environment. Studies have shown that their neutral (alkylphenols 
and short ethoxy chain ethoxylates) and acidic recalcitrant metabolites (APEC) possess the 
ability to mimic natural hormones by interacting with the estrogen receptor.  
It was estimated that approximately 60 to 65% of all nonylphenolic compounds 
introduced to WWTP are discharged into the environment; 19% in the form of 
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carboxylated derivatives, 11% in the form of lipophilic NP1EO and NP2EO, 25% in the 
form of NP and 8% as untransformed NPEOs [35]. 
However, contrary to the general believing that NPECs are the refractory 
metabolites, Di Corcia et al. [36] determined that CAPECs are the dominant products of 
the NPEO biotransformation. By averaging data relative to the treated effluents of five 
major activated sludge WWTP of Rome (Italy) over 4 months, relative abundances of 
NPEO (nEO=1 and 2), NPECs and CAPECs were found to be respectively 10±2%, 24±5% 
and 66±7%. 
The average concentrations of acidic metabolites, NPECs and CAPECs are at low 
μg/L range, however high values, up to several tens of hundreds of μg/L, are detected in 
effluents of WWTP receiving industrial wastewaters, especially from tannery, textile, pulp 
and paper industry [37]. 
 
 
4. Elimination by advance wastewater treatment processes 
 
Although, adopted as the best available technology; biological treatment permits 
only partial removal of a wide range of emerging contaminants, especially polar ones, 
which are discharge into the final effluent. Thus, it has become evident that application of 
more enhanced technologies may be crucial for the fulfilment of the requirements of an 
indirect potable reuse of municipal and industrial wastewater. In recent years, new 
technologies are being studied, not only for wastewater treatment but also for drinking 
water production. Among them membrane treatment, using both biological (membrane 
bioreactors) and non-biological processes (reversed osmosis, ultrafiltration, nanofiltration), 
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and advanced oxidation processes (AOP) are most frequently considered as treatments that 
may be appropriate to remove trace concentrations of polar emerging contaminants. 
 
4.1. Membrane processes  
 
Membrane bioreactor (MBR) technology is considered as the most promising 
development in microbiological wastewater treatment. Now, when economic reasons do no 
longer limit the application of MBR to industrial and municipal wastewater (WW) 
treatment [38] and that new requirements are being set for the treatment of WW, MBR 
treatment may become a key technique in all future scenarios that consider the direct or 
indirect reuse of wastewaters. This is due to two characteristics of MBRs, (a) the low 
sludge load in terms of BOD that can be expected to force bacteria to mineralise also 
poorly degradable organic compounds and (b) the high sludge age that gives the bacteria 
time to adapt to these substances [39,40]. 
However, although many articles have reported the application of MBR for the 
treatment of urban and industrial wastewaters, up to our knowledge there are only few 
papers reporting on the behaviour of emerging contaminants during the MBR treatment, 
and all of them dealt with nonylphenolic compounds.  
Using the MBR unit that comprises of three bioreactors and an external 
ultrafiltration unit followed by GAC adsorption, Witgens et al. [41] reported on the 
removal of more than 90% of NP in wastewater from a dumpsite leachate plant. 
Laboratory set of nanofiltration membranes resulted in retention of more than 70% of NP 
and this process was regarded as an alternative option for the final treatment of MBR 
effluent. 
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Li et al. [42] used GC-MS and LC-MS-MS to assess the elimination efficiency in 
membrane-assisted biological WWTP. The results showed that compared to conventional 
WWTP membrane assisted biological treatment with biomass concentrations of about 
20g/l could only improve elimination efficiency of NPEOs (and other ionic and non-ionic 
surfactants), but could not stop entirely the discharge with the permeates. 
 
 
4.2. Treatment by advanced oxidation processes (AOP) 
 
The AOP processes, using the combination of ozone with other oxidant agents (UV 
radiation, hydrogen peroxide, TiO2) have been studied to enhance the degradation of polar 
pharmaceuticals [43,44,45] and NPEOs metabolites [46].  Ternes et al. [45] used a pilot 
plant for ozonation and UV disinfection of effluents form a German municipal WWTP 
containing antibiotics, betablockers, antiphlogistics, lipid regulator metabolites, musk 
fragrances and iodinated X-ray contrast media. By applying 10-15 mg/l ozone (contact 
time 18 min) all the pharmaceuticals investigated were no longer detected. Exception was 
the ionic iodinated X-ray contrast compounds that exhibited removal efficiencies of not 
higher than 14%.  
In another study [44] the ozonation has been demonstrated to be a suitable tool for 
carbamazepine abatment even at the process conditions usually adopted in drinking water 
facilities. However, in spite of good primary elimination, a low degree of mineralization 
was observed and total carbon balance results lacking even for prolonged ozonation thus 
indicative the presence of some non-identified degradation products.  
However, the degradation efficiency of an AOP is limited by the radical scavenging 
capacity of the matrix of the treated water. Thus, for a sufficient degradation of the 
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pharmaceuticals (>90%) from wastewater the ozone concentration has to be equal to the 
dissolved organic carbon (DOC) value [43], which means that economic considerations 
have to prove the feasibility of the process for wastewater treatment.  
Recently, using a lab-scale reactor, Ike et al. [46] determined that the effectiveness 
of ozone treatment in the degradation of NPEO metabolites follows the order: 
NPE1C>>NP>NP1EO. Acidic metabolites were completely degraded within 4-6 min 
(initial concentration was between 0.4 and 1.0 mg/l), NP concentration reduced 75-80% in 
6 min, while only 25 to 50% of NP1EO was eliminated in the same time. 
 
 
5. Elimination by treatment processes at drinking water treatment 
plants 
 
The occurrence of organic micro-contaminants in raw water and their removal in 
the course of drinking water production and possible formation of disinfection by-products 
are key issues in relation to the quality of drinking water supplies. Although, substances 
covered by this review are currently not regulated in drinking water, precautionary 
principles should be employed, and the removal of all organic micro-contaminants should 
be as high as possible. However, several studies showed that the removal of polar 
emerging contaminants during the drinking water treatment is not complete.  
The elimination of selected pharmaceuticals (clofibric acid, diclofenac, 
carbamezapine, bezafibrate) during drinking water treatment processes was investigated at 
lab and pilot scale and in real waterworks in Germany [47]. Sand filtration under aerobic 
and anoxic conditions, as well as flocculation using iron(III)chloride exhibited no 
significant elimination of the target pharmaceuticals, while ozonation was quite effective in 
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eliminating these polar compounds. Diclofenac and carbamezapine were reduced by more 
than 90%, bezafibrate was eliminated by 50%, while clofibric acid was stable even at high 
ozone doze. Filtration with granular activated carbon (GAC), under waterworks conditions 
was very effective in removing pharmaceuticals. Exception was clofibric acid which was 
less prone to adsorption.  
The behaviour of polar alkylphenolic compounds during processing of 
contaminated water in waterworks and their possible occurrence in treated water has been 
was rarely the scope of interest and there are hardly any data available for drinking water. 
The elimination of neutral and acidic nonylphenolic compounds and their brominated and 
chlorinated derivatives, during drinking water treatment process at the waterworks that 
supply drinking water to city of Barcelona (Spain) was investigated utilizing a highly 
sensitive LC-MS-MS method [48]. The concentration of total nonylphenolic compounds: 
NPEC (nEO=0-1), NPEO (nEO=1-2) and NP; in raw water (the Llobregat river) entering 
waterworks ranged from 8.3 to 21.6 μg/L, with NPE2C being the most abundant 
compound. Prechlorination reduced the concentration of short-ethoxy chain NPECs and 
NPEOs by about 25-35%, and of NP by almost 90%. However, this reduction of 
concentrations was partially due to their transformation to halogenated derivatives. After 
prechlorination halogenated nonylphenolic compounds represented approximately 13% of 
the total metabolite pool, of which 97% were in the form of brominated acidic metabolites. 
The efficiency of further treatment steps to eliminate nonylphenolic compounds (calculated 
for the sum of all short ethoxy chain metabolites including halogenated derivatives) was as 
follows: settling and flocculation followed by rapid sand filtration (7.3%), ozonation (86.3 
%), GAC filtration (72.7%) and final disinfection with chlorine (42.8%), resulting in 
overall elimination ranging from 96.2 to 99.1% (mean 97.9% for four sampling dates) as 
shown in Fig. 2.  
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6. Conclusions 
 
The application of advanced LC-MS and GC-MS technologies to environmental 
analysis has allowed the determination of a broader range of compounds and thus 
permitted more comprehensive assessment of environmental contaminants. Among the 
various compounds considered as emerging pollutants, acidic pharmaceuticals, surfactant 
degradates and acidic pesticides are of particular concern, both because of their ubiquity in 
the aquatic environment and potential impacts. 
Elimination of these emerging contaminants during wastewater and drinking water 
treatment is not satisfactory; and an improved treatment and strict control of the treatment 
process have to be employed so that the removal of these micro-contaminants is as high as 
possible. Thus, in view of possible reuse of WWTP effluents, more research is needed to 
evaluate their behaviour and fate in the aquatic environment. Moreover, disinfection 
processes applied (either chlorination or ozonation) potentially shift the assessment of the 
risk of human consumption of the parent compound to its degradation products, which 
requires development of generic analytical protocols that will permit simultaneous 
determination of parent compounds and their metabolites.  
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Figure captions 
 
 
 
Fig. 1.  Components of a (partially) closed water cycle with indirect potable reuse 
 
 
Fig. 2.  Fate of nonylphenolic compounds during drinking water production. A) Total 
concentration of nonylphenolic compounds and their elimination during different 
treatment steps at waterworks Sant Joan Despì (Barcelona, Spain); B) Average 
composition (calculated on a molar basis) of nonylphenolic compounds in raw 
water; C) Average composition (calculated on a molar basis) of nonylphenolic 
compounds in prechlorinated water 
 
Table 1. Methods for the analysis of acidic pharmaceuticals in wastewaters 
 
Compounds Extraction Derivatization Chromatographic 
method 
Detection LOD 
(ng/L) 
Reference 
Bezafibrate, diclofenac, ibuprofen, 
gemfibrozil, carbamezapine 
Sequential SPE (C18 
+ polymeric sorbent) 
- LC MS 2 49
Salicylic acid, ibuprofen, ketoprofen, 
naproxen, bezafibrate, diclofenac 
SPE (polymeric 
sorbent) 
- LC MS 5-56 5
Bezafibrate, clofibric acid, diclofenac, 
fenoprofen, gemfibrozil, ibuprofen, 
inomethacin, ketoprofen, naproxen 
SPE (C18) - LC MS-MS 5-20 50
Bezafibrate, clofibric acid, ibuprofen SPE (MCX or 
polymeric sorbent) 
- LC MS-MS 0.016-2.18 51
Ibuprofen, clofibric acid, ketoprofen, 
naproxen, diclofenac 
SPE (HLB) diazomethane GC MS 0.3-4.5 52
Clofibric acid, diclofenac, ibuprofen, 
phenazone, propyphenazone 
SPE (C18) Pentaflorobenzyl 
bromide 
GC MS 0.6-20 53
Clofibric acid, naproxen, ibuprofen SPE (polar Empore 
disk) 
BSTFA (bis 
(trimethylsilyl)-
triflouroacetamide 
GC MS 0.4-2.6 54
Ibuprofen, naproxen, ketoprofen, tolfenamic 
acid, diclofenac, meclofenamic acid 
SPE (HLB) MTBSTFA (N-
methyl-N-(tert-
butyldimethylsilyl) 
trifluoroacetamide 
GC MS 20 55
 
Table 2. Quantitation and diagnostic ions (m/z) used for the LC-MS and GC-MS, and base peaks of precursor and product ions used for LC-MS-
MS analysis of acidic pharmaceuticals in wastewaters. Data compiled from references listed in Table 1. 
 
MS MS-MS Compound Analytical method Ionization 
mode 
SIM ions Precursor (m/z) Product 1 (m/z) Product 2 (m/z) 
Ibuprofen LC-MS NI 205, 159    
 LC-MS-MS NI  205 [M−H]− 161 [M−H−CO2]− - 
 GC-MS Positive EI 177, 220ª    
   161, 343, 386b    
   263, 278, 234c    
Diclofenac LC-MS NI 294, 250, 232    
 LC-MS-MS NI  294 [M−H]− 250 [M−H−CO2]− - 
 GC-MS Positive EI 214, 309a    
   214, 216, 475b    
   352/354/356d    
Clofibric acid LC-MS NI     
 LC-MS-MS NI  213 [M−H]− 127 [C6H4ClO]− 85 [C4H5O2]−
 GC-MS Positive EI 128, 228a    
   128, 130, 394b    
   128, 143, 286c    
Benzafibrate LC-MS NI 360, 274    
 LC-MS-MS NI  360 [M−H]− 274 [M-H-C4H6O2]− 154 [M-H-C12H14O3]−
 GC-MS Positive EI 128, 228a    
   128, 130, 394b    
Gemfibrozil LC-MS NI 249, 121    
 LC-MS-MS NI  249 [M−H]− 121 [M-H-C7H12O2]−  
Ketoprofen LC-MS NI 253, 209, 197    
 LC-MS-MS NI  253 [M−H]− 209 [M-H-CO2]−  
 GC-MS Positive EI 209, 268a    
   311d    
Naproxen LC-MS NI 229, 185, 173, 170    
 LC-MS-MS NI  229 [M−H]− 185 [M-H-CO2]− 170 [M-H-C2H3O2]−
 GC-MS Positive EI 185, 244a    
   243, 302, 185c    
   287d    
a diazomethane derivative, b pentaflourobenzyl derivative, c trimethylsilyl derivative, d tert-butyldimethylsilyl derivative 
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Table 3. Elimination at WWTP (activated sludge treatment). Data complied from references [12,28,37,52,55,56,57,58] 
 
Compound Average 
elimination 
(%)a
Effluent 
concentrations 
(μg/L) 
Main degradation 
products 
Observation 
 
Non ionic surfactants     
Alkylphenol ethoxylates  90– 99  <0.1–350 APEC, CAPEC, AP Primary degradation fast; ultimate degradation less 
than 40%, metabolites potential endocrine 
disruptors 
Pharmaceuticals     
Ibuprofen 65–90 0.37-0.60 (3.4) b   
Diclofenac 69–75 0.06-0.81 (2.1)   Rapid photodegradation 
Clofibric Acid 34–51 0.12-0.36 (1.6)   Degradation product of lipid regulating agents 
Benzafibrate 83 1.1-2.2 (4.6)   
Naproxen 45–66 0.27-0.61 (2.6)    
Ketoprofen 69 0.02-0.38 (0.87)     
Gemfibrozil 46–69 0.31-0.40 (1.9)    
Carbamazepine 7 0.30-2.1 (6.3)   Low removal rate 
Antiseptics     
Triclosan 44–92 0.070–0.650  Methyl triclosan Possible photodegradation 
Pesticides     
Mecoprop and MCPA - 20–400  2-methyl-4-Cl-phenol Application period (mid-March until mid-May) 
2,4-D - <20  2,4-dichlorphenol  
2,4,5-T - <20 2,4-D ; 2,4-dichlorphenol  
a Primary elimination of the parent compound  
b Range of average values detected (in parenthesis: maximum concentration detected) 
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